Evidence map›Paper›PMID 38290477›Full record

ArticleActa haematologica2024

Attitudes towards COVID-19 Vaccination in Adults with Haematological Malignancies.

Richard Blennerhassett, Nada Hamad, Lisa Grech, Alastair Kwok, Tammie Choi, Cecily Forsyth, Jacqueline Jagger, Stephen Opat, Sam Harris, Bryan Anthony Chan and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta haematologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Richard BlennerhassettCentral Coast Haematology, North Gosford, New South Wales, Australia.
Nada HamadDepartment of Haematology, St Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia.
Lisa GrechDepartment of Medicine, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia.
Alastair KwokDepartment of Medicine, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia, alastair.kwok@monash.edu.
Tammie ChoiDepartment of Nutrition, Dietetics, and Food, Monash University, Notting Hill, Victoria, Australia.
Cecily ForsythCentral Coast Haematology, North Gosford, New South Wales, Australia.
Jacqueline JaggerCentral Coast Haematology, North Gosford, New South Wales, Australia.
Stephen OpatDepartment of Medicine, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia.
Sam HarrisDepartment of Medical Oncology, Bendigo Health, Bendigo, Victoria, Australia.
Bryan Anthony ChanDepartment of Oncology, Sunshine Coast Hospital and Health Service, Birtinya, Queensland, Australia.
Mike NguyenDepartment of Medicine, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia.
Nathan BainDepartment of Oncology, Monash Health, Clayton, Victoria, Australia.
Daphne DayDepartment of Medicine, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia.
Eva SegelovDepartment of Medicine, School of Clinical Sciences, Monash University, Clayton, Victoria, Australia.
CANVACCS Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDespite people with haematological malignancies being particularly vulnerable to severe COVID-19 infection and complications, vaccine hesitancy may be a barrier to optimal vaccination. This study explored attitudes towards COVID-19 vaccination in people with haematological malignancies.

methodsPeople with haematological malignancies at nine Australian health services were surveyed between June and October 2021. Sociodemographic and clinical characteristics were collected. Attitudes towards COVID-19 vaccination were explored using the Oxford COVID-19 Vaccine Hesitancy Scale, the Oxford COVID-19 Vaccine Confidence and Complacency Scale, and the Disease Influenced Vaccine Acceptance Scale-Six. Open-ended comments were qualitatively analysed.

resultsA total of 869 people with haematological malignancies (mean age 64.2 years, 43.6% female) participated. Most participants (85.3%) reported that they had received at least one COVID-19 vaccine dose. Participants who were younger, spoke English as a non-dominant language, and had a shorter time since diagnosis were less likely to be vaccinated. Those who were female or spoke English as their non-dominant language reported greater vaccine side-effect concerns. Younger participants reported greater concerns about the vaccine impacting their treatment.

conclusionPeople with haematological malignancies reported high vaccine uptake; however, targeted education for specific participant groups may address vaccine hesitancy concerns, given the need for COVID-19 vaccine boosters.

Indexed as

COVID-19COVID-19 VaccinesHematologic NeoplasmsVaccination HesitancyAdultAgedAged, 80 and overAustraliaFemaleHealth Knowledge, Attitudes, PracticeHumansMaleMiddle AgedPatient Acceptance of Health CareSurveys and QuestionnairesCOVID-19 VaccinesCOVID-19COVID-19 vaccinesHematological malignanciesVaccination

Identifiers

PMID38290477
PMCPMC11441379

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.